Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by.
Dare Bioscience Inc. (DARE)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 13,279 | $24,168 | -26% | 0% |
| 2. | Renaissance Technologies Jim Simons | 10,195 | $18,555 | -48% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.10 | 454,545 | $499,999.50 | 944,956 | 2019-04-11 | Filing | |
| $1.45 | 140,000 | $203,378.00 | 140,000 | 2018-06-11 | Filing | |
| $2.09 | 591 | $1,234.19 | 167,491 | 2016-02-22 | Filing | |
| $2.08 | 1,700 | $3,529.03 | 166,900 | 2016-02-19 | Filing | |
| $2.09 | 4,500 | $9,400.95 | 165,200 | 2016-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 462,305 | $841,395 | 0% | |
| 2. | 177,839 | $323,703 | 0% | |
| 3. | 91,370 | $166,293 | 0% | |
| 4. | 65,938 | $120,007 | 0% | |
| 5. | 43,363 | $78,921 | 0% |
News See All
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2025 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's third quarter 2025 financial results and to provide a business update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2025 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience Therapeutics Company's Second Quarter 2025 Financial Results and to provide a business update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Conference Call hosted by Daré Bioscience to review the company's First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's 2024 Financial Results and to provide a Business Update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2024 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's Third Quarter Financial Results and to provide a general business update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q2 2024 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's second quarter financial results and to provide a general business update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2024 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the company's First Quarter Financial Results and to provide the General Business Update. This call is being recorded.
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript
Operator: Welcome to the conference hosted by Daré Bioscience to Review the Company's Third Quarter Financial Results and to provide a General Business Update. This call is being recorded.
Hedge Fund Resource Center